Gulf Pharmaceutical Industries has announced the appointment of the company's associate director finance, Laurent de Chazeaux, as acting chief financial officer - effective immediately. He replaces Jerome Carle, who has been promoted as the general manager of Julphar. As acting CFO, de Chazeaux will be responsible for leading the company's finance department and keeping accurate financial records.

He will be in charge of the administrative and risk management operations and will develop financial strategies in line with Julphar's objectives. Over the last 20 years, de Chazeaux has worked in a number of senior finance roles in the pharmaceutical industry and in investment banking. He spent several years working for Cowen, where he was in charge of analyzing performances of midsize European pharmaceutical companies, and before joining Julphar as Associate Director Finance in June 2017, he worked at Sanofi and as Finance Director at AstraZeneca.